news.png

News

Cyclica has been selected for the Life Sciences CTA in San Francisco

TORONTO, Canada – Cyclica has been selected to participate in the Life Sciences Canadian Technology Accelerator program in San Francisco beginning in October 2013. With nearby Silicon Valley, the Bay Area is a technology start-up and venture capital hotbed, and the heart of one of North America’s largest and most vibrant biotechnology clusters. This is an ideal spot for Cyclica, as our market includes the hundreds of pharma and biotech companies in the area, as well as a significant R&D cluster for many major pharma companies. Read the press release here